BRPI0518637A2 - agentes para controlar os fluidos biolàgicos e mÉtodos de uso dos mesmos - Google Patents

agentes para controlar os fluidos biolàgicos e mÉtodos de uso dos mesmos

Info

Publication number
BRPI0518637A2
BRPI0518637A2 BRPI0518637-4A BRPI0518637A BRPI0518637A2 BR PI0518637 A2 BRPI0518637 A2 BR PI0518637A2 BR PI0518637 A BRPI0518637 A BR PI0518637A BR PI0518637 A2 BRPI0518637 A2 BR PI0518637A2
Authority
BR
Brazil
Prior art keywords
methods
formulations
patient
weight
agents
Prior art date
Application number
BRPI0518637-4A
Other languages
English (en)
Inventor
John P Kennedy
Curtis E Ii Jones
Original Assignee
Southeastern Medical Technolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southeastern Medical Technolog filed Critical Southeastern Medical Technolog
Publication of BRPI0518637A2 publication Critical patent/BRPI0518637A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

AGENTES PARA CONTROLAR OS FLUIDOS BIOLàGICOS E MÉTODOS DE USO DOS MESMOS. Formulações terapêuticas adaptadas para a aplicação por pressão positiva, para o controle de fluido biológico em um local desejado em um paciente, artigos absorventes que compreendem as formulações terapêuticas, e dispositivos antiinfectivos revestidos com as formulações terapêuticas, as ditas formulações compreendendo cerca de 25% a cerca de 99% em peso de composto formador de cristal líquido e 0% a cerca de 75% em peso de solvente. Além disso, divulgam-se métodos de utilizar as ditas formulações, incluindo os métodos para controlar o fluido biológico em um local desejado em um paciente, os métodos para controlar a perda de sangue, e os métodos para facilitar o fechamento efetivo de um local de ferida vascular ou incisão em um local desejado em um paciente, os métodos compreendendo administrar formulações particulares que compreendem compostos formadores de cristais líquidos e solventes que são descritos neste documento.
BRPI0518637-4A 2004-12-13 2005-12-13 agentes para controlar os fluidos biolàgicos e mÉtodos de uso dos mesmos BRPI0518637A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/009,623 US20060127437A1 (en) 2004-12-13 2004-12-13 Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
PCT/US2005/045034 WO2006065800A2 (en) 2004-12-13 2005-12-13 Agents for controlling biological fluids and methods of use thereof

Publications (1)

Publication Number Publication Date
BRPI0518637A2 true BRPI0518637A2 (pt) 2008-12-02

Family

ID=36584209

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518637-4A BRPI0518637A2 (pt) 2004-12-13 2005-12-13 agentes para controlar os fluidos biolàgicos e mÉtodos de uso dos mesmos

Country Status (9)

Country Link
US (1) US20060127437A1 (pt)
EP (1) EP1830895A2 (pt)
JP (1) JP2008523149A (pt)
KR (1) KR20070100733A (pt)
CN (1) CN101184513A (pt)
AU (1) AU2005316579A1 (pt)
BR (1) BRPI0518637A2 (pt)
CA (1) CA2595132C (pt)
WO (1) WO2006065800A2 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
WO2006088912A2 (en) * 2005-02-15 2006-08-24 Virginia Commonwealth University Mineral technologies (mt) for acute hemostasis and for the treatment of acute wounds and chronic ulcers
US20070020228A1 (en) * 2005-07-22 2007-01-25 Williams Terry N Method of using a biosealant device
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
KR20090061022A (ko) * 2006-08-30 2009-06-15 사우쓰이스턴 메디칼 테크놀로지스, 엘엘씨 대기압에서 변경된 압력으로 상처를 치료하는 방법, 조성물및 기구
EP2162283B1 (en) * 2007-06-14 2015-08-12 Massachusetts Institute of Technology Self assembled films for protein and drug delivery applications
ES2745949T3 (es) * 2007-07-19 2020-03-04 Imerys Talc America Inc Recubrimientos de silicona, procedimientos para hacer artículos recubiertos con silicona y artículos recubiertos a partir de los mismos
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
US8333787B2 (en) * 2007-12-31 2012-12-18 St. Jude Medical Puerto Rico Llc Vascular closure device having a flowable sealing material
US8795718B2 (en) * 2008-05-22 2014-08-05 Honeywell International, Inc. Functional nano-layered hemostatic material/device
US9242027B2 (en) 2008-07-18 2016-01-26 Cornell University Fabrication of a vascular system using sacrificial structures
WO2010021973A2 (en) * 2008-08-17 2010-02-25 Massachusetts Institute Of Technology Controlled delivery of bioactive agents from decomposable films
DE102009029194A1 (de) 2009-09-04 2011-04-07 Kimberly-Clark Worldwide, Inc., Neenah Abtrennung gefärbter Stoffe aus wasserhaltigen Flüssigkeiten
NZ600403A (en) 2009-12-08 2014-01-31 Smith & Nephew Orthopaedics Ag Enzymatic wound debriding compositions with enhanced enzymatic activity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
ITMI20101849A1 (it) * 2010-10-11 2012-04-12 Antonio Battista Composizione emostatica e suoi usi
DE102011016277B4 (de) * 2011-04-06 2013-02-21 Heraeus Medical Gmbh Plastisch verformbares, biodegradierbares Hämostyptikum und Verfahren zum Formen eines solchen
US9561300B2 (en) 2011-09-26 2017-02-07 Yes, Inc. Hemostatic compositions and dressings for bleeding
US9161869B2 (en) 2012-03-30 2015-10-20 Kimberly-Clark Worldwide, Inc. Absorbent articles with decolorizing agents
US10278927B2 (en) 2012-04-23 2019-05-07 Massachusetts Institute Of Technology Stable layer-by-layer coated particles
KR102375103B1 (ko) 2012-06-22 2022-03-16 지-메디카 엘엘씨 지혈 장치
WO2014091007A1 (en) * 2012-12-14 2014-06-19 Merz Pharma Gmbh & Co. Kgaa Patch comprising an onion extract
WO2014134029A1 (en) 2013-02-26 2014-09-04 Massachusetts Institute Of Technology Nucleic acid particles, methods and use thereof
US9463244B2 (en) 2013-03-15 2016-10-11 Massachusetts Institute Of Technology Compositions and methods for nucleic acid delivery
US9237975B2 (en) 2013-09-27 2016-01-19 Kimberly-Clark Worldwide, Inc. Absorbent article with side barriers and decolorizing agents
EP3096793A1 (en) * 2013-10-07 2016-11-30 Boston Scientific Scimed, Inc. Injectable compositions
CN103989701B (zh) * 2014-05-12 2016-06-08 中国人民解放军第二军医大学 聚乙二醇4000或聚乙二醇6000在制备预防或治疗水母毒素心脏毒性药物中的应用
KR101867247B1 (ko) * 2014-07-15 2018-06-12 미쓰이 가가쿠 가부시키가이샤 외상 치료제 및 외상 치료 재료
CN104622801B (zh) * 2015-02-13 2017-12-01 广州医科大学附属第二医院 羟基喜树碱的立方液晶前体组合物及其制备方法和应用
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
CN106075537B (zh) * 2016-06-24 2019-02-12 浙江夏舒生物科技有限公司 一种冷感凝胶材料及其制备方法与应用
CN106491519B (zh) * 2016-12-09 2020-01-21 广州中大南沙科技创新产业园有限公司 局部麻醉药的立方液晶原位凝胶注射剂及其制备方法
KR101921727B1 (ko) * 2016-12-28 2018-11-23 주식회사 제네웰 실리콘 수지 조성물, 이의 제조방법 및 이를 포함하는 흉터 치료제
CN106620660A (zh) * 2016-12-30 2017-05-10 深圳市新指南医学科技发展有限公司 一种止血喷雾剂
EP3595624A1 (en) * 2017-03-13 2020-01-22 Kayapan, Satya Dharshan A novel composition obtainable from extra virgin olive oil and methods of preparation thereof
GB201711183D0 (en) 2017-07-12 2017-08-23 Smith & Nephew Antimicrobial or wound care materials, devices and uses
GB201711181D0 (en) 2017-07-12 2017-08-23 Smith & Nephew Polymer foam material, device and use
GB201711179D0 (en) 2017-07-12 2017-08-23 Smith & Nephew Wound care materials, devices and uses
FR3071150A1 (fr) * 2017-09-16 2019-03-22 Francois Forestier Bioreacteur fibrinogene-thrombine
US11419947B2 (en) 2017-10-30 2022-08-23 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
CN116019960A (zh) * 2018-10-17 2023-04-28 东丽株式会社 止血材料
JP7389418B2 (ja) * 2019-02-18 2023-11-30 青葉化成株式会社 止血剤
US12018315B2 (en) 2019-05-30 2024-06-25 Massachusetts Institute Of Technology Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids
JP7395153B2 (ja) * 2020-04-01 2023-12-11 富士フイルム株式会社 抗血栓性材料
CN115252875B (zh) * 2021-04-29 2023-06-16 浙江大学 一种医用组织粘合胶及其制备方法
US11872105B1 (en) 2022-12-01 2024-01-16 Robert Parker Dental implant device for regeneration of dental pulp and dentin
US11931224B1 (en) 2022-12-19 2024-03-19 Robert Parker Tooth pod
CN116144068B (zh) * 2022-12-20 2024-04-23 武夷学院 烷基化壳聚糖/海藻酸钠复合海绵材料的制备方法及其用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK116528A (pt) * 1966-09-30
US4331653A (en) * 1977-08-18 1982-05-25 Robert Brown Composition for a topical cream for curtailing bleeding and treating skin disorders
SE442705B (sv) * 1979-05-08 1986-01-27 Viktor Kare Larsson Medel for bildande av ett skyddsskikt pa ett underlag i form av hud eller slemhinna samt forfarande for att bilda ett skyddsskikt pa huden i icke-terapeutiskt syfte med hjelp av detta medel
EP0073790B1 (en) * 1981-03-17 1985-07-24 Biogram AB A germicidal composition
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE462894B (sv) * 1985-10-28 1990-09-17 Biogram Ab Mikrokapslar, foerfarande foer framstaellning daerav samt anvaendning
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
US4759354A (en) * 1986-11-26 1988-07-26 The Kendall Company Wound dressing
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5060642A (en) * 1990-01-05 1991-10-29 Gilman Thomas H Wound dressing with air permeable bacteria impermeable reservoir
CA2154286A1 (en) * 1993-01-12 1994-07-21 Nancy M. Newman Invisible bandage assembly
US5160328A (en) * 1991-08-07 1992-11-03 Ndm Acquisition Corp. Hydrogel bandage
DE69229640T2 (de) * 1991-10-04 1999-12-16 Gs Development Ab, Malmoe Teilchen, methode zur herstellung der teilchen und deren verwendung
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
US5393798A (en) * 1992-06-05 1995-02-28 Spenco Medical Corporation Hydrogel material and method of preparation
EP0721348B1 (en) * 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
DE69530914T2 (de) * 1994-02-17 2004-03-11 New York Blood Center, Inc. Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung
US6228383B1 (en) * 1994-03-03 2001-05-08 Gs Development Ab Use of fatty acid esters as bioadhesive substances
US5858392A (en) * 1994-03-22 1999-01-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Supported polyionic hydrogels
WO1995026715A2 (en) * 1994-03-30 1995-10-12 Dumex-Alpharma A/S Use of fatty acid esters as bioadhesive substances
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
WO1996039125A1 (en) * 1995-06-06 1996-12-12 University Of Nebraska Board Of Regents Composition and method for administration of bio-affecting catalysts
GB9521125D0 (en) * 1995-10-16 1995-12-20 Unilever Plc Cosmetic composition
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
JPH09169653A (ja) * 1995-12-22 1997-06-30 Unitika Ltd キチン止血剤
GB9617001D0 (en) * 1996-08-13 1996-09-25 Tillotts Pharma Ag Oral composition
SE511313C2 (sv) * 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
ZA987019B (en) * 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
SE9802528D0 (sv) * 1998-07-13 1998-07-13 Gs Dev Ab Bone tissue restoring composition
US6312725B1 (en) * 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
WO2000071183A1 (en) * 1999-05-21 2000-11-30 3M Innovative Properties Company Antimicrobial articles
US6537569B2 (en) * 2001-02-14 2003-03-25 Microvention, Inc. Radiation cross-linked hydrogels
US6568398B2 (en) * 2001-03-07 2003-05-27 Edgar C. Cohen Method for hemostasis
CN1582140A (zh) * 2001-03-09 2005-02-16 庄臣及庄臣有限公司 具有改善的皮肤和材料柔软的护肤品
JP4875804B2 (ja) * 2001-07-06 2012-02-15 ユニチカ株式会社 止血材
US6488952B1 (en) * 2001-08-28 2002-12-03 John P. Kennedy Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
WO2003057307A1 (en) * 2001-12-26 2003-07-17 Hill-Rom Services, Inc. Wound vacuum therapy dressing kit
JP2004026653A (ja) * 2002-03-04 2004-01-29 Mitsuru Akashi ハイドロキシアパタイト−ポリマー複合材料の止血用組成物
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof

Also Published As

Publication number Publication date
WO2006065800A3 (en) 2006-09-21
CA2595132C (en) 2015-05-05
CA2595132A1 (en) 2006-06-22
JP2008523149A (ja) 2008-07-03
AU2005316579A1 (en) 2006-06-22
US20060127437A1 (en) 2006-06-15
KR20070100733A (ko) 2007-10-11
EP1830895A2 (en) 2007-09-12
WO2006065800A2 (en) 2006-06-22
CN101184513A (zh) 2008-05-21

Similar Documents

Publication Publication Date Title
BRPI0518637A2 (pt) agentes para controlar os fluidos biolàgicos e mÉtodos de uso dos mesmos
WO2007070561A3 (en) Agents for controlling biological fluids and methods of use thereof
WO2007127390A3 (en) Materials and methods for wound treatment
BRPI0412527A (pt) composto, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica, e, processo para preparar um composto.
BRPI0517263A (pt) novos derivados de sulfonamida como moduladores do receptor de glicocorticóide para o tratamento de doenças inflamatórias
BRPI0409136A (pt) composto heteroaromático pentacìclico e uso medicinal do mesmo
BRPI0706992C1 (pt) composto de fórmula (i) e formulação farmacêutica
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BRPI0511235A (pt) preparado tópico e método para a administração transdérmica e localização de agentes terapêuticos
BRPI0511504A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides
EA200900638A1 (ru) СОЛИ И КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 2-МЕТИЛ-2-[4-(3-МЕТИЛ-2-ОКСО-8-ХИНОЛИН-3-ИЛ-2,3-ДИГИДРОИМИДАЗО[4,5-c]ХИНОЛИН-1-ИЛ)ФЕНИЛ]ПРОПИОНИТРИЛА
BRPI0513565A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, métodos para inibir uma atividade de proteìna cinase, e para tratar um paciente tendo uma condição que é mediada por atividade de proteìna cinase, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
BRPI0409372A (pt) composições e métodos para regular o tecido queratinoso de mamìferos
GT200900194A (es) Derivados de espirocromanona sustituida como inhibidores de acc.
BRPI0413595A (pt) sal de succinato ou sal de malonato, sal cristalino de hidrogeno malonato, composição farmacêutica, uso de um sal, método de fabricação de um composto, e, composto
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
BRPI0410979A (pt) composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia
BRPI0713755A8 (pt) composto ou um sal ou solvato do mesmo, uso do composto ou um sal ou salvato do mesmo, composição farmacêutica,e, processo para a preparação de um composto ou um sal ou solvato do mesmo
BRPI0617436B8 (pt) derivado heterocíclico fundido, composição farmacêutica compreendendo o mesmo e usos do dito derivado na prevenção ou tratamento de doença dependente de hormônio sexual e na regulação da reprodução, contracepção ou indução de ovulação
DK1885187T3 (da) Fremgangsmåde til behandling af lægemiddelresistent cancer
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BRPI0405657A (pt) Método para o tratamento de insuficiência cardìaca grave e medicamento para o mesmo
BR0008006A (pt) Métodos e composições para uso em aplicações deperfusão
BRPI0411246A (pt) composto, uso do mesmo, composição farmacêutica, e, métodos para terapia contra dor em um animal de sangue quente e para a preparação de um composto
SE0102147D0 (sv) New methods

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.